Systolic BP Variability powerful determinant of CV outcome; amlodipine may render long-term benefit: confirms ASCOT trial
UK: Systolic blood pressure variability (SBPV) is a strong predictor of cardiovascular (CV) outcomes, even in those with controlled systolic blood pressure (SBP), according to the ASCOT trial. The findings, published in the European Heart Journal, highlight the importance of SBPV as an additional marker of CV risk and affirm the superiority of amlodipine versus […]